SCHEMBL2343308

SCHEMBL2343308

Fc1ccc(-n2c(N3CCNCC3)cc3ccccc32)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 8/20 0.47
▸ ADRB1 P08588 4/20 0.43
▸ HTR3E A5X5Y0 3/20 0.43
▸ HTR3B O95264 3/20 0.43
▸ HTR3A P46098 3/20 0.43
▸ HTR3D Q70Z44 3/20 0.43
▸ HTR3C Q8WXA8 3/20 0.43
▸ SIGMAR1 Q99720 3/20 0.43
▸ HTR5A P47898 1/20 0.43
▸ HTT P42858 2/20 0.40
▸ HTR2A P28223 2/20 0.40
▸ HTR2C P28335 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2346369 0.86 ADRB1 (0.53) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2345155 0.81 HTR1A (0.44) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL11555106 0.80 HTR3E (0.53) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2345082 0.78 HTR3E (0.48) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL232655 0.77 ADRB1 (0.71) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2346242 0.76 ADRB1 (0.60) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2352062 0.76 RXFP1 (0.43) HTTNPSR1RXFP1ABCG2
Hydrochloric Acid SCHEMBL4897454 0.75 ADRB1 (0.69) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2342043 0.75 HTR3A (0.56) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL2348309 0.75 HTR3A (0.44) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback